These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27271454)

  • 1. Serum C-reactive protein and S100A12 concentrations in dogs with hepatic disease.
    Craig SM; Fry JK; Rodrigues Hoffmann A; Manino P; Heilmann RM; Suchodolski JS; Steiner JM; Hottinger HA; Hunter SL; Lidbury JA
    J Small Anim Pract; 2016 Sep; 57(9):459-64. PubMed ID: 27271454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy.
    Heilmann RM; Nestler J; Schwarz J; Grützner N; Ambrus A; Seeger J; Suchodolski JS; Steiner JM; Gurtner C
    Vet Immunol Immunopathol; 2019 May; 211():64-74. PubMed ID: 31084897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biomarkers adiponectin, leptin, C-reactive protein, S100A12, and the Acute Patient Physiologic and Laboratory Evaluation (APPLE) score as mortality predictors in critically ill dogs.
    Köster LS; Fosgate GT; Suchodolski J; Lidbury J; Steiner JM
    J Vet Emerg Crit Care (San Antonio); 2019 Mar; 29(2):154-160. PubMed ID: 30861273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of S100A12 and S100A8/A9 (calprotectin) in dogs with sepsis or the systemic inflammatory response syndrome.
    Thames BE; Barr JW; Suchodolski JS; Steiner JM; Heilmann RM
    J Vet Diagn Invest; 2019 Jul; 31(4):645-651. PubMed ID: 31170888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potential serum biomarkers of hepatic fibrosis and necroinflammatory activity in dogs with liver disease.
    Raghu C; Ekena J; Cullen JM; Webb CB; Trepanier LA
    J Vet Intern Med; 2018 May; 32(3):1009-1018. PubMed ID: 29485210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum calgranulin C is a highly sensitive autoinflammation activity indicator in patients with familial periodic fevers].
    Bogdanova MV; Rameev VV; Kozlovskaya LV; Fedorov ES; Salugina SO
    Ter Arkh; 2016; 88(6):58-64. PubMed ID: 27296263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum calprotectin (S100A8/A9) concentrations and idiopathic hyperlipidemia in Miniature Schnauzers.
    Heilmann RM; Xenoulis PG; Müller K; Stavroulaki EM; Suchodolski JS; Steiner JM
    J Vet Intern Med; 2019 Mar; 33(2):578-587. PubMed ID: 30788872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A12 concentrations and myeloperoxidase activities are increased in the intestinal mucosa of dogs with chronic enteropathies.
    Hanifeh M; Sankari S; Rajamäki MM; Syrjä P; Kilpinen S; Suchodolski JS; Heilmann RM; Guadiano P; Lidbury J; Steiner JM; Spillmann T
    BMC Vet Res; 2018 Apr; 14(1):125. PubMed ID: 29618371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum haptoglobin concentrations in dogs with liver disease.
    Crawford K; Warman SM; Marques AI; Yool DA; Eckersall PD; McCulloch E; Lynn K; Mellanby RJ; Gow AG
    Vet Rec; 2013 Dec; 173(23):579. PubMed ID: 24158322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum biochemical marker concentrations and survival time in dogs with protein-losing enteropathy.
    Equilino M; Théodoloz V; Gorgas D; Doherr MG; Heilmann RM; Suchodolski JS; Steiner JM; Burgener Dvm IA
    J Am Vet Med Assoc; 2015 Jan; 246(1):91-9. PubMed ID: 25517330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum S100A12 as a prognostic biomarker of severe traumatic brain injury.
    Feng MJ; Ning WB; Wang W; Lv ZH; Liu XB; Zhu Y; Gao W; Jin HZ; Gao SS
    Clin Chim Acta; 2018 May; 480():84-91. PubMed ID: 29408171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum S100A12 and 30-day mortality after acute intracerebral hemorrhage.
    Qian SQ; He SR; Li BB; Qian J; Zheng XD
    Clin Chim Acta; 2018 Feb; 477():1-6. PubMed ID: 29196185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential effects of calcium binding protein S100A12 on severity evaluation and curative effect of severe acute pancreatitis.
    Feng Z; Yinchu Z; Yinsheng S; Fengqing W; Xiaoyang Z; Jin L; Xiaofei G
    Inflammation; 2015 Feb; 38(1):290-7. PubMed ID: 25266882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum concentrations of neutrophil-derived protein S100A12 in heterozygous carriers of MEFV mutations.
    Lieber M; Kallinich T; Lohse P; Klotsche J; Holzinger D; Foell D; Wittkowski H
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S113-6. PubMed ID: 26486615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
    Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal S100A12 concentration predicts a lack of response to treatment in dogs affected with chronic enteropathy.
    Heilmann RM; Volkmann M; Otoni CC; Grützner N; Kohn B; Jergens AE; Steiner JM
    Vet J; 2016 Sep; 215():96-100. PubMed ID: 27017054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of S100A12 and soluble receptor for advanced glycation end products on the occurrence of severe acute pancreatitis.
    Zhao B; Chen Y; Sun WW; Chen WW; Ma L; Yang ZT; Huang J; Chen EZ; Fei J; Mao EQ
    J Dig Dis; 2016 Jul; 17(7):475-82. PubMed ID: 27251034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum S100A12 concentrations are correlated with angiographic coronary lesion complexity in patients with coronary artery disease.
    Liu J; Ren YG; Zhang LH; Tong YW; Kang L
    Scand J Clin Lab Invest; 2014 Mar; 74(2):149-54. PubMed ID: 24341566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.